Updated Jul 16, 2026
RIGBY JONATHAN has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jonathan Rigby is identified as a director of Oncolytics Biotech Inc in SEC filings with the most recent filing dated June 3, 2026. Beyond this filing, publicly available biographical information about his background, education, and career history is not provided in the context available.
| Role | Director |
|---|---|
| Notability | 20/100 |
Jonathan Rigby is identified as a director of Oncolytics Biotech Inc in SEC filings with the most recent filing dated June 3, 2026. Beyond this filing, publicly available biographical information about his background, education, and career history is not provided in the context available.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live RIGBY JONATHAN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.